FLGT – Fulgent Genetics, Inc.

Fulgent Genetics, Inc.

FLGT

$19.68

Name : Fulgent Genetics, Inc.

Sector : Healthcare

Industry: Diagnostics & Research

Mark. Cap: $599,130,048.00

EPSttm : -1.33

Fulgent Genetics, Inc.

$19.68

0.41%

$0.08

Float Short %

8.4

Margin Of Safety %

Put/Call OI Ratio

0.03

EPS Next Q Diff

-0.24

EPS Last/This Y

0.86

EPS This/Next Y

-0.08

Price

19.7

Target Price

22.67

Analyst Recom

2.67

Performance Q

16.8

Relative Volume

1.08

Beta

1.04

Ticker: FLGT

19 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-06-02	FLGT	20.71	0.03	0.00	18931
2025-06-03	FLGT	21.19	0.04	0.00	18793
2025-06-04	FLGT	21.28	0.03	0.03	18956
2025-06-05	FLGT	20.83	0.04	0.00	18863
2025-06-06	FLGT	21.44	0.04	0.72	18743
2025-06-09	FLGT	21.82	0.03	0.00	18660
2025-06-10	FLGT	21.81	0.03	0.07	18640
2025-06-11	FLGT	21.74	0.04	0.01	18442
2025-06-12	FLGT	20.99	0.04	0.00	18377
2025-06-13	FLGT	20.7	0.04	0.01	18445
2025-06-16	FLGT	20.92	0.03	0.00	18983
2025-06-17	FLGT	20.29	0.03	0.09	19530
2025-06-18	FLGT	20.33	0.03	1.88	19517
2025-06-20	FLGT	19.53	0.04	0.03	19568
2025-06-23	FLGT	19.29	0.03	0.00	18654
2025-06-24	FLGT	19.51	0.03	0.01	18574
2025-06-25	FLGT	19.57	0.03	0.00	18685
2025-06-26	FLGT	19.63	0.03	0.01	18745
2025-06-27	FLGT	19.67	0.03	0.09	18875
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

19 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-06-02	FLGT	20.67	-223.2	18.7	-0.55
2025-06-03	FLGT	21.17	-223.2	16.4	-0.55
2025-06-04	FLGT	21.28	-223.2	18.1	-0.55
2025-06-05	FLGT	20.82	-223.2	20.5	-0.55
2025-06-06	FLGT	21.43	-223.2	16.0	-0.55
2025-06-09	FLGT	21.81	-223.2	17.0	-0.55
2025-06-10	FLGT	21.82	-223.2	18.6	-0.55
2025-06-11	FLGT	21.75	-223.2	18.7	-0.55
2025-06-12	FLGT	20.99	-223.2	21.4	-0.55
2025-06-13	FLGT	20.70	-223.2	19.7	-0.55
2025-06-16	FLGT	20.95	-223.2	17.5	-0.55
2025-06-17	FLGT	20.26	-223.2	21.5	-0.55
2025-06-18	FLGT	20.30	-223.2	18.4	-0.55
2025-06-20	FLGT	19.53	-223.2	22.0	-0.55
2025-06-23	FLGT	19.30	-223.2	19.7	-0.55
2025-06-24	FLGT	19.55	-223.2	17.5	-0.55
2025-06-25	FLGT	19.59	-223.2	18.2	-0.55
2025-06-26	FLGT	19.62	-223.2	18.5	-0.55
2025-06-27	FLGT	19.70	-223.2	18.1	-0.55
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-06-02	FLGT	0.88	-12.84	9.03
2025-06-03	FLGT	0.86	-12.84	9.03
2025-06-04	FLGT	0.86	-12.84	9.03
2025-06-05	FLGT	0.89	-12.84	9.03
2025-06-06	FLGT	0.89	-12.84	9.03
2025-06-09	FLGT	0.89	-12.93	9.02
2025-06-10	FLGT	0.89	-12.93	9.02
2025-06-11	FLGT	0.89	-12.93	8.20
2025-06-12	FLGT	0.89	-12.93	8.20
2025-06-13	FLGT	0.89	-12.93	8.20
2025-06-16	FLGT	0.89	-12.87	8.20
2025-06-17	FLGT	0.89	-12.87	8.20
2025-06-18	FLGT	0.89	-12.87	8.20
2025-06-20	FLGT	0.89	-12.87	8.20
2025-06-23	FLGT	0.89	-13.18	8.20
2025-06-24	FLGT	0.89	-13.18	8.20
2025-06-25	FLGT	0.89	-13.18	8.20
2025-06-26	FLGT	0.89	-13.18	8.40
2025-06-27	FLGT	0.89	-13.18	8.40
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

0.04

Avg. EPS Est. Current Quarter

-0.18

Avg. EPS Est. Next Quarter

-0.2

Insider Transactions

0.89

Institutional Transactions

-13.18

Beta

1.04

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

89.6

Max Drawdown 5-Year %

-91.7

Target Price

22.67

P/E

Forward P/E

PEG

P/S

2.05

P/B

0.53

P/Free Cash Flow

EPS

-1.34

Average EPS Est. Cur. Y

-0.55

EPS Next Y. (Est.)

-0.63

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-13.94

Relative Volume

1.08

Return on Equity vs Sector %

-27.5

Return on Equity vs Industry %

-14.2

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.1

EBIT Estimation

18.1

Fulgent Genetics, Inc.

Sector: Healthcare

Industry: Diagnostics & Research

Employees: 1313

Fulgent Genetics, Inc. provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer services related to hereditary cancer, reproductive health, and other diseases. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform to enhance the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The company operates picture genetics platform, which includes gene probes, data suppression and comparison algorithms, adaptive learning software, and proprietary laboratory information management systems that helps customers to identify health markers in their personal DNA. It serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, municipalities and large corporations, and patients. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. The company was founded in 2011 and is headquartered in El Monte, California.

stock quote shares FLGT – Fulgent Genetics, Inc. Stock Price stock today

news today FLGT – Fulgent Genetics, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch FLGT – Fulgent Genetics, Inc. yahoo finance google finance

stock history FLGT – Fulgent Genetics, Inc. invest stock market

stock prices FLGT premarket after hours

ticker FLGT fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

FLGT – Fulgent Genetics, Inc.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: FLGT

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y